AWM
BNGO icon

Activest Wealth Management’s Bionano Genomics BNGO Stock Holding History

Activest Wealth Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3 Hold
3
– – ﹤0.01% 1338
2026
Q1 		$4 Hold
3
– – ﹤0.01% 1223
2025
Q4 		$5 Hold
3
– – ﹤0.01% 1115
2025
Q3 		$5 Hold
3
– – ﹤0.01% 1138
2025
Q2 		$10 Hold
3
– – ﹤0.01% 1021
2025
Q1 		$8 Hold
3
– – ﹤0.01% 1030
2024
Q4 		$58 Hold
3
– – ﹤0.01% 737
2024
Q3 		$91 Hold
3
– – ﹤0.01% 526
2024
Q2 		$136 Buy
+3
New +$165 ﹤0.01% 492

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CWP
Concord Wealth Partners Abingdon, Virginia $873M AUM 24.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Activest Wealth Management's BNGO Position: Q2 2026 in Review

Activest Wealth Management held its Bionano Genomics (BNGO) position steady in Q2 2026 at 3 shares worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #1338.

Activest Wealth Management first reported a position in BNGO in Q2 2024 and has held it in 9 quarters since. The position peaked at $136 in Q2 2024. 9 funds tracked by Wall St. Rank hold BNGO as of Q2 2026.

  • Activest Wealth Management held 3 shares of Bionano Genomics worth $3 as of Q2 2026.
  • Activest Wealth Management left its Bionano Genomics share count unchanged in Q2 2026.
  • Bionano Genomics made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #1338 holding.
  • Activest Wealth Management first reported a position in Bionano Genomics in Q2 2024 and has held it in 9 quarters since.
  • Activest Wealth Management's Bionano Genomics position peaked at $136 in Q2 2024.
  • 9 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.